Adèle Telenius

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

Christian Steidl, Sohrab P. Shah, Bruce W. Woolcock et al. · Nature · 2011 · 612 citations

Medicine, Genetics, Oncology +16

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

David W. Scott, Anja Mottok, Daisuke Ennishi et al. · Journal of Clinical Oncology · 2015 · 406 citations · Full text

Medicine, Oncology, Pathology +17

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma

Robert Kridel, Barbara Meissner, Sanja Rogić et al. · Blood · 2011 · 334 citations · Full text

Medicine, Molecular Genetics, Oncology +15

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

Daisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin et al. · Cancer Discovery · 2019 · 316 citations

Medicine, Hematology, Oncology +17

Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma

David D. W. Twa, Fong Chun Chan, Susana Ben‐Neriah et al. · Blood · 2014 · 297 citations

Medicine, Molecular Genetics, Oncology +16